Medical Genetics is the branch of medicine and biomedical science concerned with the role of genetic variation and inheritance in human health, disease, diagnosis, prognosis, prevention, and treatment. It encompasses inherited disorders, chromosomal abnormalities, single gene conditions, multifactorial disease susceptibility, genomic variation, cancer genetics, pharmacogenetics, and genetic counselling. The field examines how genetic information is transmitted between generations and how changes in DNA or chromosome structure can affect biological function.
Medical genetics distinguishes germline variants, which may be present in reproductive cells and therefore potentially inherited, from somatic variants that arise in individual tissues during life. It also recognises that not every genetic variant causes disease and that pathogenicity depends on factors including variant type, gene function, allele dosage, inheritance pattern, genetic background, developmental context, and environmental interaction. The field therefore extends well beyond identifying mutations and requires interpretation of how particular genomic findings relate to individual and family phenotypes.
The history of medical genetics developed through observations of familial disease, studies of inheritance, cytogenetics, molecular biology, and eventually genomic sequencing. Early inheritance studies established statistical principles describing transmission patterns, while cytogenetic techniques later made it possible to visualise chromosomes and identify large structural abnormalities and changes in chromosome number. Molecular techniques enabled individual genes and variants to be investigated, and sequencing technologies eventually expanded genetic analysis from selected genes to whole exomes and whole genomes.
The Human Genome Project and subsequent advances in sequencing, annotation, computational analysis, and population genomics greatly expanded the ability to identify and interpret genetic variation. Modern medical genetics consequently operates at several scales, from single nucleotide changes and small insertions or deletions to copy number changes, structural variants, repeat expansions, mitochondrial variants, and complex genomic rearrangements. Historical progress has also demonstrated that discovering a genetic association is only one stage of understanding disease because biological function and clinical significance require independent evidence.
Genetic inheritance can follow several recognised patterns, including autosomal dominant, autosomal recessive, X linked, mitochondrial, and more complex inheritance mechanisms. Autosomal dominant disorders can manifest when one pathogenic allele is sufficient to cause disease, although penetrance may be incomplete and expressivity may vary. Autosomal recessive disorders generally require pathogenic variants affecting both relevant alleles, while carriers may have no clinically significant phenotype.
X linked conditions can show characteristic transmission patterns because males and females differ in sex chromosome composition, although the clinical effects depend on the particular disorder and biological mechanism. Mitochondrial inheritance is distinctive because mitochondrial DNA is generally transmitted maternally. Complex traits involve many genetic variants of small or variable effect and are strongly influenced by environment and other biological factors. Pedigree analysis, segregation studies, population frequency, functional evidence, and molecular testing can help determine whether a variant and phenotype are plausibly related.
Chromosomal and genomic abnormalities constitute a major area of medical genetics. Numerical abnormalities can involve extra or missing chromosomes, while structural abnormalities include deletions, duplications, inversions, translocations, and other rearrangements. Some abnormalities are constitutional and occur throughout the body, whereas mosaic abnormalities affect only a subset of cells because genetic change occurred after fertilisation. Chromosomal microarray analysis can detect many copy number changes, while karyotyping remains useful for visualising larger chromosomal structures.
Fluorescence based methods can investigate specific genomic regions, and sequencing can detect many sequence level variants. No single genetic test detects every possible type of genomic abnormality, so test selection depends on the suspected mechanism and clinical question. A negative test therefore does not necessarily exclude a genetic disorder because limitations can arise from the technology, genomic region examined, variant type, mosaicism, interpretation, or current knowledge of disease associated genes.
Genetic diagnosis increasingly depends on variant interpretation rather than merely variant detection. Laboratories and clinicians consider population frequency, computational evidence, segregation, functional studies, phenotype matching, previous clinical observations, and established disease mechanisms when evaluating variants. Variants may be classified into categories reflecting different levels of evidence for pathogenicity, but classification can change as new evidence accumulates. A variant initially considered uncertain may later become better understood, while a previous interpretation can sometimes be revised when additional data contradict earlier assumptions.
The distinction between a pathogenic variant and a risk associated variant is particularly important. Some variants strongly increase disease probability but do not guarantee disease, while others have high penetrance and more predictable effects. Genetic results must therefore be interpreted within the patient's phenotype and family history rather than treated as deterministic statements about future health.
Medical genetics has important clinical applications in diagnosis, reproductive medicine, cancer care, screening, prognosis, and treatment selection. Genetic counselling helps individuals and families understand inheritance, possible outcomes, limitations of testing, reproductive implications, and the meaning of uncertain results. Prenatal testing, newborn screening, carrier testing, predictive testing, and diagnostic testing address different clinical questions and involve different ethical considerations. Cancer genetics can identify inherited predisposition to particular malignancies, while tumour sequencing can identify somatic alterations relevant to classification or treatment. Pharmacogenetics examines whether inherited genetic variation influences drug metabolism, transport, efficacy, or adverse effects. Gene based therapies are also developing, including approaches designed to replace, modify, silence, or otherwise alter disease associated genetic mechanisms, although applicability and long term outcomes vary considerably between conditions.
Genetic information raises distinctive ethical, legal, and social questions because it can concern family members as well as the individual tested. A genetic result may reveal information about relatives who have not undergone testing, establish unexpected biological relationships, or indicate future disease susceptibility. Issues of informed consent, confidentiality, data storage, secondary use of genomic information, discrimination, reproductive decision making, and communication within families therefore require careful consideration.
Population screening must balance potential benefits from early detection against false positives, overdiagnosis, anxiety, uncertain findings, and unequal access. Genetic testing in children raises additional questions about whether information should be generated before the child can make an informed decision, particularly when the result concerns conditions that are unlikely to affect childhood. Ethical practice requires that genetic information be interpreted accurately and communicated with appropriate uncertainty rather than presented as a deterministic prediction.
Common misconceptions include the belief that genes completely determine health or that every identified DNA difference represents a harmful mutation. Human genomes contain extensive normal variation, and many variants have little or no known clinical consequence. Another misconception is that a negative genetic test proves that a condition has no genetic component. Genetic testing is constrained by technology and current knowledge, and many disorders involve genes or mechanisms that may not yet be identifiable.
Medical genetics is increasingly integrating genomic sequencing with electronic phenotypes, functional experiments, population databases, family studies, and computational interpretation. Its significance extends beyond rare inherited disorders because genetic variation influences common diseases, drug responses, tumour biology, immune function, development, and many physiological traits. Accurate medical genetics therefore requires simultaneous attention to molecular biology, inheritance, statistical evidence, clinical phenotype, family context, technological limitations, and the evolving nature of genomic knowledge.
